Lack of association of VEGF promoter polymorphisms with sporadic ALS

Neurology

Volumn 67, Issue 3, 2006, Pages 508-510

  Chen, W ^a   Saeed, M ^a   Mao, H ^a   Siddique, N ^a   Dellefave, L ^a   Hung, W Y ^a   Deng, H X ^a   Sufit, R L ^a   Heller, S L ^a   Haines, J L ^b   Pericak Vance, M ^c   Siddique, T ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33747037794     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000227926.42370.04     Document Type: Article

References (10)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
2. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-1235.
3. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001;28:131-138.
4. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-394.
5. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-309.
6. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" workshop contributors. J Neurol Sci 1994;124:96-107.
7. Haviland MB, Kassling AM, Davingnon J, Sing CF. Estimation of Hardy-Weinberg pairwise disequilibrium in apolipoprotein AI-CIII-AIV gene cluster. Am J Hum Genet 1991;49:350-365.
8. Van Vught PW, Sutedja NA, Veldink JH, et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 2005;65:1643-1645.
9. Gros-Louis F, Laurent S, Lopes AA, et al. Absence of mutations in the hypoxia response element of VEGF in ALS. Muscle Nerve 2003;28:774-775.
10. Brockington A, Kirby J, Eggitt D, et al. Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics 2005;6:101-104.